| Title |
Author |
Type |
Date |
Words |
| Addition of obinutuzumab (GA101) or rituximab to chlorambucil Improves Outcomes for Elderly Patients With Chronic Lymphocytic Leukemia (CLL) and Co-Existing Medical Conditions (Comorbidities). |
|
|
Jun 14, 2013 |
394 |
| Non-Toxic, Non-Surgical Medical Cancer Therapies Finally Available in the U.S. |
|
|
Jun 12, 2013 |
484 |
| L01 antineoplastic agents antineoplastic agents and v03af detoxified and v04cx82 other diagnostic agents and therapeutic radiopharmaceuticals and other v10xx0 r03dx05 other systemic effects of roads o. |
|
|
Jun 8, 2013 |
138 |
| Antineoplastic drugs and detoksitseerivate purchase. |
|
|
Jun 8, 2013 |
103 |
| Antineoplastic agents . |
|
|
Jun 8, 2013 |
127 |
| A WOMAN denied a lifesaving drug believes she's [...]; GRAN WOULD GET CANCER DRUG IF SHE LIVED IN ENGLAND. |
|
|
Jun 6, 2013 |
453 |
| it would be available if she lived in England. [...]; GRAN WOULD GET CANCER DRUG IF SHE LIVED IN ENGLAND. |
|
|
Jun 6, 2013 |
453 |
| SentoClone International AB Significantly Strengthens its Global Patent Portfolio Covering its Clinical Stage Sentinel Node-derived CD4 T-cell Cancer Therapy. |
|
|
Jun 5, 2013 |
783 |
| Targeted cancer therapy pioneers tapped to receive the 2013 $100,000 Taubman Prize. |
|
|
Jun 5, 2013 |
920 |
| SentoClone International AB Significantly Strengthens its Global Patent Portfolio Covering its Clinical Stage Sentinel Node-derived CD4 T-cell Cancer Therapy. |
|
|
Jun 5, 2013 |
787 |
| Antineoplastic agents . |
|
|
Jun 5, 2013 |
135 |
| New Research: Modified Citrus Pectin - A Potent Anti-Cancer Therapy. |
|
|
Jun 4, 2013 |
869 |
| Canada : Phase 3 DECISION Trial Investigating the Use of Nexavar (sorafenib) Demonstrated Significant Improvement in Progression-Free Survival in Patients with Radioactive Iodine-Refractory Differenti. |
|
|
Jun 4, 2013 |
323 |
| Skin cancer drugs bring fresh hope; MELANOMA. |
|
|
Jun 3, 2013 |
115 |
| Skin cancer drugs bring fresh hope. |
|
|
Jun 3, 2013 |
105 |
| Phase 3 DECISION Trial Investigating the Use of Nexavar (sorafenib) Demonstrated Significant Improvement in Progression-Free Survival in Patients with Radioactive Iodine-Refractory Differentiated Thyroid Cancer. |
|
|
Jun 2, 2013 |
2541 |
| War on cancer: 3BP and the metabolic approach to cancer: a visit with Peter Pedersen and Young Hee Ko. |
Moss, Ralph |
|
Jun 1, 2013 |
2825 |
| North trials for 'last chance' cancer drug; Cutting off energy supply to the cells. |
|
|
May 31, 2013 |
841 |
| Prometheus Laboratories Launches PROCLIVITY 02, a Phase IV Multi-Center Study Comparing the Sequence of Proleukin (Aldesleukin for Injection) and Yervoy (Ipilimumab) in Patients with Metastatic Melanoma. |
|
|
May 30, 2013 |
1890 |
| Lack of cancer drugs in Turkey leads to black market boom. |
|
|
May 28, 2013 |
278 |
| Dr. Dean Bottino, Roche, to Discuss Multi-Scale Modeling in Development of Cancer Drugs in Rosa's Impact Webinar Series. |
|
|
May 28, 2013 |
628 |
| Sorrento Therapeutics, Inc. and IGDRASOL present Phase I clinical data for the combination of CynviloqTM (paclitaxel polymeric micelle) plus gemcitabine for treatment of advanced pancreatic cancer at ASCO 2013 (booth #2090). |
|
|
May 28, 2013 |
1093 |
| Lack of Cancer Medicines in Turkey Leads to Black Market Boom. |
|
|
May 28, 2013 |
269 |
| Scientists cast doubt on Alzheimer's cancer drug study. |
|
|
May 27, 2013 |
484 |
| Canada : Soricimed Biopharma Inc. Announces U.S. Trial Site for Phase I Clinical Trial of New Cancer Drug, SOR-C13. |
|
|
May 24, 2013 |
352 |
| Anti-cancer drug reverses Alzheimer's disease deficits in mice. |
|
|
May 24, 2013 |
460 |
| 50-pills girl Ellie beats leukaemia; HEALTH. |
|
|
May 23, 2013 |
110 |
| Delivery of drugs, antineoplastic agents included in the positive list of medicines / plc / treatment of patients with cancer, according to an established specification for the needs of shato "st. min. |
|
|
May 22, 2013 |
112 |
| AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy. |
|
|
May 20, 2013 |
1719 |
| AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy. |
|
|
May 20, 2013 |
1786 |
| GRAN FORCED TO MOVE TO SAVE HER LIFE; Cancer drug is only available in England. |
|
|
May 17, 2013 |
376 |
| Tests suggest new drug could help treat leukaemia. |
|
|
May 16, 2013 |
213 |
| Leukaemia sufferers' drug hope. |
|
|
May 16, 2013 |
239 |
| Shares rocket after cancer drug trials. |
|
|
May 15, 2013 |
460 |
| New Roche Award for Antibody-based Cancer Therapy Research. |
|
|
May 15, 2013 |
627 |
| Antineoplastic agents . |
|
|
May 15, 2013 |
103 |
| China : TO Sell Vectibix in China Amgen forms Joint Venture. |
|
|
May 13, 2013 |
325 |
| China : VECTIBIX will be marketed through joint venture between Amgen and Zhejiang Beta Pharma. |
|
|
May 13, 2013 |
154 |
| Mouse study shows cancer drug halts accumulation of toxic proteins linked to Parkinson's disease. |
|
|
May 11, 2013 |
577 |
| Prometheus Laboratories Inc. Launches PROCLIVITY(SM) 01 Clinical Trial of Proleukin (Aldesleukin for Injection) Plus Vemurafenib Therapy in Patients with Metastatic Melanoma. |
|
|
May 9, 2013 |
1607 |
| The Market for Pancreatic Cancer Therapies Will Nearly Double to $1.3 Billion in 2022, Fueled by the Entry of Three Novel Agents. |
|
|
May 7, 2013 |
505 |
| Mycafungina drug delivery and oncology: docetaxel, pemetrexed, doxorubicinum. |
|
|
May 7, 2013 |
168 |
| Antineoplastic agents . |
|
|
May 4, 2013 |
144 |
| New target for personalized cancer therapy discovered. |
|
|
May 3, 2013 |
381 |
| Antineoplastic agents . |
|
|
May 3, 2013 |
130 |
| Cancer drug could hold promise for weight loss. |
|
|
Apr 24, 2013 |
457 |
| Research Foundations Collaborate To Fund Phase 1 Study Of Cancer Drug In Alzheimer's Disease Patients. |
|
|
Apr 24, 2013 |
866 |
| Antineoplastic agents . |
|
|
Apr 24, 2013 |
175 |
| Antineoplastic agents . |
|
|
Apr 23, 2013 |
116 |
| Bipartisan Group of 124 Lawmakers Express Concern That Medicare Cuts to Life-Sustaining Cancer Drugs Threatening Patient Care. |
|
|
Apr 23, 2013 |
639 |
| Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail. |
|
|
Apr 23, 2013 |
2362 |
| New tailor-made compound could lead to potential anti-cancer agents. |
|
|
Apr 22, 2013 |
358 |
| Galapagos discovers novel cancer drug. |
|
|
Apr 22, 2013 |
128 |
| Antineoplastic agents . |
|
|
Apr 20, 2013 |
115 |
| Antineoplastic agents . |
|
|
Apr 17, 2013 |
133 |
| India's decision on blockbuster cancer drug makes good sense. |
|
|
Apr 17, 2013 |
995 |
| Emu oil may help treat damage caused by cancer chemotherapy. |
|
|
Apr 16, 2013 |
189 |
| Mendelsohn To Talk Personalized Cancer Therapy at Bush Library and Museum April Issues Forum. |
|
|
Apr 16, 2013 |
657 |
| Eisai Announces Preclinical Research Findings Suggesting Novel Infibitory Effect on Tumor Metastasis for Anticancer Agent Halaven(R) at AACR 104th Annual Meeting. |
|
|
Apr 10, 2013 |
932 |
| Canada : Dr. Jake Thiessen to Lead Independent Review of Cancer Drug System. |
|
|
Apr 10, 2013 |
322 |
| Provision Antineoplastic agents. |
|
|
Apr 5, 2013 |
105 |
| Cancer drug fear as cash running out; health. |
|
|
Apr 4, 2013 |
132 |
| QVC and Fashion Footwear Association of New York Invest in Personalized Breast Cancer Therapy Research. |
|
|
Apr 4, 2013 |
903 |
| Provision of Antineoplastic agents. |
|
|
Apr 3, 2013 |
129 |
| Merrimack Pharmaceuticals To Present Preclinical Research On Five Novel Cancer Therapies. |
|
|
Apr 2, 2013 |
731 |
| India : Supreme Court denial of Glivec patent clarifies limited intellectual property protection and discourages future innovation in India. |
|
|
Apr 2, 2013 |
414 |
| Setback for Novartis in its bid for cancer drug patent. |
|
|
Apr 2, 2013 |
720 |
| Novartis loses landmark India patent case on Glivec, govt hails 'historic' SC verdict. |
|
|
Apr 1, 2013 |
154 |
| SC rejection of Novartis patent for cancer drug a win win situation for cheaper foreign drugs in India. |
|
|
Apr 1, 2013 |
231 |
| SC dismisses Novartis' plea to patent cancer drug. |
|
|
Apr 1, 2013 |
158 |
| Novartis Loses Bid To Patent New Version Of Glivec In India, Giving A Boost To Country's $26B Generic Drug Industry. |
|
|
Apr 1, 2013 |
495 |
| Sorrento Therapeutics, Inc. and IGDRASOL Announce Three Presentations on Cynviloq(TM) (IG-001; paclitaxel polymeric micelle) at the American Association of Cancer Research (AACR) Meeting. |
|
|
Mar 31, 2013 |
1287 |
| Anaeropharma Science Initiates First-in-Human Trial of Novel Recombinant Bifidobacterial Anti-cancer Agent APS001F for Advanced Solid Tumors. |
|
|
Mar 28, 2013 |
448 |
| Premier Biomedical, Inc. Announces Next Phase of Laboratory Testing of its Anti-Cancer Therapy. |
|
|
Mar 28, 2013 |
613 |
| United States Oncology Drug Delivery Preferences and Opportunities in Cancer Drug Delivery. |
|
|
Mar 27, 2013 |
889 |
| Novel T-cell therapy cures aggressive leukemia in 2 kids. |
|
|
Mar 26, 2013 |
356 |
| T-Cell Therapy Eradicates an Aggressive Leukemia in Two Children. |
|
|
Mar 25, 2013 |
1884 |
| Provide Antineoplastic agents. |
|
|
Mar 22, 2013 |
246 |
| Cellular Biomedicine Group Marks the Launch of China Clinical Trial for TC-DC Therapy for Hepatocellular Carcinoma. |
|
|
Mar 21, 2013 |
856 |
| H3 Biomedicine and BGI Announce Collaboration to Develop and Share Crucial Cancer Genomic Sequencing Data. |
|
|
Mar 21, 2013 |
1046 |
| Cancer drug shortages mean higher costs and greater risk for patients. |
|
|
Mar 21, 2013 |
1122 |
| Spectrum Pharmaceuticals, Inc. Sued by Shareholders. |
|
|
Mar 21, 2013 |
662 |
| St. Jude Children's Research Hospital announces issuance of U.S. patent for genetically modified human immune cells for cancer therapy. |
|
|
Mar 19, 2013 |
540 |
| Antineoplastic agents . |
|
|
Mar 19, 2013 |
141 |
| Antineoplastic agents . |
|
|
Mar 15, 2013 |
108 |
| With policy shift, pricier prostate cancer drug use rises. |
Schneider, Mary Ellen |
|
Mar 15, 2013 |
461 |
| Breast cancer drug gets the go-ahead; Sufferers will benefit from new treatment. |
|
|
Mar 14, 2013 |
614 |
| 'It's a good day for women with breast cancer' - BARONESS DELYTH MORGAN; DRUG TO EXTEND LIFE FOR 2,000 A YEAR. |
|
|
Mar 14, 2013 |
254 |
| 'It's a good day for women with breast cancer' - BARONESS DELYTH MORGAN; DRUG TO EXTEND LIFE FOR 2,000 A YEAR. |
|
|
Mar 14, 2013 |
249 |
| It's a good day for women with breast cancer; DRUG TO EXTEND LIFE FOR 2,000 A YEAR- BARONESS DELYTH MORGAN. |
|
|
Mar 14, 2013 |
254 |
| Breast cancer drug gets the green light; New treatment, partly pioneered in city and shown to reduce risk of death, is licensed in UK. |
|
|
Mar 14, 2013 |
418 |
| United States Oncology Drug Delivery Preferences and Opportunities in Cancer Drug Delivery. |
|
|
Mar 13, 2013 |
868 |
| Leica Biosystems and Synthon Biopharmaceuticals Partner to Develop a Companion Diagnostic Program for Targeted Cancer Therapies. |
|
|
Mar 12, 2013 |
569 |
| Leica Biosystems and Synthon Biopharmaceuticals Partner to Develop a Companion Diagnostic Program for Targeted Cancer Therapies. |
|
|
Mar 12, 2013 |
574 |
| Drugs and Diagnostics for Hematological Disorders: Global Markets. |
|
|
Mar 12, 2013 |
7475 |
| Drug giant loses appeal to halt sale of cheaper pills. |
|
|
Mar 6, 2013 |
258 |
| German drug maker Bayer to challenge India's ruling allowing cheaper cancer drug copy. |
|
|
Mar 6, 2013 |
228 |
| Research and Markets: Lupron Depot (Prostate Cancer) - Forecast and Market Analysis to 2022. |
|
|
Mar 6, 2013 |
446 |
| India rejects Bayer plea against cheap cancer drug. |
|
|
Mar 5, 2013 |
687 |
| MolecularHealth demonstrates Personalized Cancer Therapy Solutions at 2013 CeBIT. |
|
|
Mar 5, 2013 |
479 |
| Presage Biosciences Announces Strategic Research Alliance with Celgene Corporation. |
|
|
Mar 5, 2013 |
642 |
| Signed an agreement to supply cancer drugs, for the period of 12 months, in order to have the necessary drugs to dispense medical care in a timely manner, ensuring a high standard of quality and conti. |
|
|
Mar 5, 2013 |
138 |
| Tosedostat OPAL Study in Acute Myeloid Leukemia Published in Lancet Oncology. |
|
Clinical report |
Mar 4, 2013 |
1434 |
| Advanced Cell Diagnostics Initiates Agreement to Study Biomarkers for Cancer Immunotherapy. |
|
|
Mar 4, 2013 |
713 |
| Tokai Pharmaceuticals to Present Data on Galeterone in Advanced Prostate Cancer at 2013 International Congress on Targeted Anticancer Therapies (TAT). |
|
|
Mar 4, 2013 |
823 |
| Fungi inspires potential cancer drugs. |
|
|
Feb 28, 2013 |
618 |
| Henry's Tavern Event Seeks Bone Marrow Donor for Aidan Peterson. |
|
|
Feb 28, 2013 |
1020 |
| Taiho Pharmaceutical Submits Application for Approval to Manufacture and Market Novel Antitumor Agent TAS-102. |
|
|
Feb 27, 2013 |
1058 |
| Taiho Pharmaceutical Submits Application for Approval to Manufacture and Market Novel Antitumor Agent TAS-102. |
|
|
Feb 27, 2013 |
1065 |
| Araxes Pharma Enters Into Cancer Drug Discovery and Development Agreement With Janssen Biotech. |
|
|
Feb 27, 2013 |
542 |
| Blueprint Medicines Welcomes David Schenkein, M.D., to Its Board of Directors. |
|
|
Feb 25, 2013 |
621 |
| US approves new targeted breast cancer drug. |
|
|
Feb 23, 2013 |
193 |
| Global Leaders in Oncology Voice Support for WIN Consortium's 2013 Symposium in Personalized Cancer Medicine. |
|
|
Feb 22, 2013 |
468 |
| Research and Markets: Kidney Cancer Drugs - 2012 Global Business Strategic Report Profiles 19 Companies Including Many Key and Niche Players. |
|
Report |
Feb 21, 2013 |
395 |
| ARIAD Announces Appointment of European General Manager and Other Key Members of Leadership Team. |
|
|
Feb 21, 2013 |
1240 |
| Abbott to Collaborate with Janssen and Pharmacyclics on Development of Companion Test for Investigational Leukemia Therapy. |
|
|
Feb 21, 2013 |
665 |
| RVC Biofund Portfolio Company to Contribute to Development of Cancer Therapy. |
|
|
Feb 20, 2013 |
1006 |
| Marine mussels inspire 'glue' for surgical repair and cancer drug delivery. |
|
|
Feb 18, 2013 |
455 |
| Valve Connectors Designed to Prevent Cytotoxic Drug Exposure to Medical Workers Utilize Bayer MaterialScience Plastic. |
|
|
Feb 18, 2013 |
700 |
| The WIN Consortium and the UC San Diego Moores Cancer Center Become Partners in Advancing Personalized Cancer Medicine. |
|
|
Feb 18, 2013 |
421 |
| Research and Markets: Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2012. |
|
|
Feb 18, 2013 |
407 |
| Research and Markets: Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H2 2012. |
|
|
Feb 18, 2013 |
431 |
| Research and Markets: Global Non-small Cell Lung Cancer Drugs Market 2012-2016. |
|
|
Feb 18, 2013 |
670 |
| Over $6,000 for Leukemia Society Raised by Stanbridge College Nursing Student. |
|
|
Feb 17, 2013 |
650 |
| Opponents of cancer drug fund 'just plain ignorant' Policy doesn't hurt the NHS, says minister. |
|
|
Feb 16, 2013 |
482 |
| Cancer Drugs Fund 'has not hurt the NHS' TORY CLAIMS CRITICS ARE LYING OR 'IGNORANT'. |
|
|
Feb 16, 2013 |
627 |
| New potential drug target for cancer identified. |
|
|
Feb 14, 2013 |
458 |
| Risk of Leukemia After Cancer Chemotherapy Persists. |
|
|
Feb 14, 2013 |
1062 |
| NIH study finds increases in risk of certain leukemias related to treatment. |
|
Report |
Feb 14, 2013 |
111 |
| New Publication in Science Shows That Agios IDH1 Inhibitor Can Reverse Cancer-Causing Effects of Oncometabolite 2-HG in Leukemia Model. |
|
|
Feb 13, 2013 |
661 |
| Sequenta Launches ClonoSIGHT, First Sequencing-Based Minimal Residual Disease Test for Leukemia and Lymphoma. |
|
|
Feb 13, 2013 |
476 |
| New PROVENGE[R] (sipuleucel-T) Data to Be Presented at 2013 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium. |
|
|
Feb 13, 2013 |
1694 |
| Research and Markets: Islet Cell Carcinoma (Insulinoma) - Pipeline Review, H2 2012. |
|
|
Feb 13, 2013 |
317 |
| Antineoplastic and immunomodulating agents. |
|
|
Feb 13, 2013 |
101 |
| Antineoplastic agents. |
|
|
Feb 13, 2013 |
193 |
| The Market for Breast Cancer Therapies in the BRIC Countries Will Grow at an Annual Rate of Eight Percent From $1.7 Billion to $2.5 Billion Between 2012 and 2017. |
|
|
Feb 13, 2013 |
812 |
| Lymphoid leukemia's 'Achilles' heel' discovered. |
|
|
Feb 12, 2013 |
396 |
| Antineoplastic agents. |
|
|
Feb 12, 2013 |
112 |
| Pharmacyclics First to Announce Breakthrough Therapy Designation in Oncology from the U.S. Food and Drug Administration. |
|
|
Feb 12, 2013 |
1737 |
| Hospital pays for six-year-old leukemia patient's treatment in Al... |
|
|
Feb 11, 2013 |
222 |
| e-Therapeutics to Raise GBP 40 Million to Advance Lead Cancer Drug and Exploit Network Pharmacology Platform. |
|
|
Feb 11, 2013 |
662 |
| MEI Pharma Adds Cancer Drug Development Veteran Tom Reynolds to Board of Directors. |
|
|
Feb 11, 2013 |
864 |
| Study Finds Lymphoid Leukemia's Weak Spot. |
|
|
Feb 11, 2013 |
887 |
| Inmate 'lucky' to get trial of cancer drugs. |
|
|
Feb 10, 2013 |
377 |
| New cancer drug saves 3-year-old; RESEARCH. |
|
|
Feb 9, 2013 |
164 |
| I need cancer drug now but Mr Salmond just shrugged it off; HOLYROOD HEALTH DEBATE; Dying Anne denied help English sick are allowed. |
|
|
Feb 8, 2013 |
701 |
| I need cancer drug now but Mr Salmond just shrugged it off; HOLYROOD HEALTH DEBATE; Dying Anne denied help English sick are allowed. |
|
|
Feb 8, 2013 |
712 |
| Oncolytics Biotech[R] Inc. Announces Additional Positive REOLSYIN[R] Clinical Trial Data from Phase 2 Study in Squamous Cell Carcinoma of the Lung. |
|
Report |
Feb 8, 2013 |
836 |
| Research and Markets: Hepatocellular Carcinoma - Pipeline Review, H2 2012. |
|
|
Feb 8, 2013 |
415 |
| United Kingdom : GSK announces European submission for MEK monotherapy and BRAF/MEK combination therapy in metastatic melanoma. |
|
|
Feb 8, 2013 |
385 |
| United Kingdom : The synthesis of tricholomenyns a and b - novel natural product with potential in cancer chemotherapy. |
|
|
Feb 8, 2013 |
282 |
| The Expected Approval of Velcade Will Be a Significant Driver of Growth in the Graft Versus Host Disease Drug Market. |
|
|
Feb 7, 2013 |
606 |
| Research and Markets: Burkitt Lymphoma - Pipeline Review, H2 2012. |
|
|
Feb 6, 2013 |
419 |
| One Million Americans with Blood Cancer in Jeopardy of Losing Access to Needed Medications. |
|
|
Feb 6, 2013 |
766 |
| Potential new anti-cancer therapy discovered. |
|
|
Feb 5, 2013 |
411 |
| The Market for Squamous Cell Carcinoma of the Head and Neck is Characterized by High Unmet Need of Treatment Options Based on Specific Tumor Biology. |
|
|
Feb 5, 2013 |
814 |
| Acceleron Initiates Phase 2 Study of Dalantercept (ACE-041) to Treat Patients with Metastatic Renal Cell Carcinoma. |
|
|
Feb 5, 2013 |
724 |
| Amino Up Chemical's AHCC on Breast Cancer Chemotherapy Is Reported by The University of Tokyo. |
|
|
Feb 5, 2013 |
458 |
| AIBioTech[TM] Announces a New Test to Assess L-asparaginase Levels in Patients Undergoing Treatment for Acute Lymphoblastic Leukemia. |
|
|
Feb 4, 2013 |
536 |
| The Treatment Landscape for Thyroid Carcinoma Will Change Dramatically Through 2021. |
|
|
Feb 4, 2013 |
671 |
| Miracle drug hope rises for leukaemia tot. |
|
|
Feb 3, 2013 |
201 |
| NEW MIRACLE DRUG HOPE FOR CHARLIE; Two-year-old with leukaemia could undergo trial. |
|
|
Feb 2, 2013 |
386 |
| Research and Markets: Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2012. |
|
|
Feb 1, 2013 |
409 |
| Research and Markets: Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2012. |
|
|
Feb 1, 2013 |
426 |
| Health Canada Approves ADCETRIS[R] (Brentuximab Vedotin) for the Treatment of Relapsed or Refractory Hodgkin Lymphoma (HL) and Systemic Anaplastic Large Cell Lymphoma (sALCL). |
|
|
Feb 1, 2013 |
1301 |
| A medicopolitical plot in Austria against the natural anticancer agent Ukrain. |
Jurasunas, Serge |
|
Feb 1, 2013 |
3945 |
| Post-docetaxel options for further survival benefit in metastatic castration-resistant prostate cancer: Questions of choice. |
Asselah, Jamil; Sperlich, Catherine |
|
Feb 1, 2013 |
3029 |
| AVEO, Astellas report kidney cancer drug tivozanib matches Bayer/Onyz Nexavar. |
|
|
Feb 1, 2013 |
236 |
| Obinutuzumab (GA101) Significantly Improved Progression-Free Survival in People With Chronic Lymphocytic Leukemia (CLL). |
|
Clinical report |
Jan 31, 2013 |
1320 |
| Daiichi Sankyo and ArQule Enroll First Hepatocellular Carcinoma Patient into Global Phase 3 Trial for Tivantinib. |
|
|
Jan 31, 2013 |
1468 |
| CBIS Releases Corporate Operational Guidance for 2013 as the Company Reorganizes to better meet the Growing Global Crisis Associated with Anti-Retroviral Drug Resistance among People with AIDS, as well as the Increasing Need for Patient Friendly Skin Cancer Therapies. |
|
|
Jan 31, 2013 |
1708 |
| Please Mr Neil, help my mum get drug before it is too late; LOVING SON AIDEN, 10, WRITES TO HEALTH MINISTER OVER MOTHER'S CANCER FIGHT. |
|
|
Jan 31, 2013 |
581 |
| Research and Markets: Rituxan (Rheumatoid Arthritis) Forecast and Market Analysis 2012-2022. |
|
|
Jan 30, 2013 |
393 |
| Launch Of Premium-priced, Novel Targeted Therapies Will Drive Growth In The Acute Leukemia Markets Beginning In 2015. |
|
|
Jan 30, 2013 |
810 |
| Stress reduces effectiveness of prostate cancer therapies. |
|
|
Jan 29, 2013 |
165 |
| Dr. Alex Matter Awarded 2013 Szent-Gyorgyi Prize for Progress in Cancer Research. |
|
|
Jan 29, 2013 |
1230 |
| Spectrum Pharmaceuticals Announces Presentation of Belinostat Safety Profile from BELIEF Registrational Phase 2 Trial at the Fifth Annual T-Cell Lymphoma Forum. |
|
|
Jan 28, 2013 |
1345 |
| Stress reduces effectiveness of prostate cancer therapies. |
|
|
Jan 27, 2013 |
185 |
| Antineoplastic and immunomodulating agents. |
|
|
Jan 24, 2013 |
291 |
| 60SECONDS ON.. KAPOSI'S SARCOMA. |
|
|
Jan 24, 2013 |
109 |
| 60 SECONDS ON.. KAPOSI'S SARCOMA. |
|
|
Jan 24, 2013 |
109 |
| Research and Markets: Burkitt Lymphoma Global Clinical Trials Review, H2, 2012. |
|
|
Jan 24, 2013 |
462 |
| TechNavio Announces the Publication of Its Research Report - Global Non-Small Cell Lung Cancer Drugs Market 2012-2016. |
|
|
Jan 24, 2013 |
479 |
| Seattle Genetics and Millennium Initiate Global Phase III Clinical Trial of ADCETRIS[R] (Brentuximab Vedotin) in Front-line CD30-Expressing Mature T-Cell Lymphoma (MTCL). |
|
|
Jan 24, 2013 |
2062 |
| Research and Markets: Glioma Global Clinical Trials Review, H2, 2012. |
|
|
Jan 24, 2013 |
332 |
| The Leukemia & Lymphoma Society and Avella Specialty Pharmacy to Present Free Event on Oral Chemotherapy Drugs. |
|
|
Jan 24, 2013 |
764 |
| Anti-cancer drug developer wins PS600k to work on new technology; BIOTECH FIRM 'SIGNIFICANTLY AHEAD' OF REVENUE FORECAST. |
|
|
Jan 23, 2013 |
505 |
| EntreMed Announces Initiation Of Phase 2 Trial In Advanced/Metastatic Soft Tissue Sarcoma. |
|
|
Jan 23, 2013 |
1107 |
| Cash Store Sponsors Big D Climb to Support Leukemia & Lymphoma Society. |
|
|
Jan 23, 2013 |
445 |
| Scottsdale Healthcare, TGen study shows Abraxane/gemcitabine combination extends survival of pancreatic cancer patients. |
|
|
Jan 22, 2013 |
1115 |
| Research and Markets: B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2012. |
|
|
Jan 21, 2013 |
415 |
| Antineoplastic agents. |
|
|
Jan 19, 2013 |
122 |
| Various medicinal products. |
|
|
Jan 19, 2013 |
357 |
| Pfizer's Bosutinib Receives Positive Opinion For Conditional Marketing Authorization From The Committee For Medicinal Products For Human Use For The Treatment Of Ph+ Chronic Myelogenous Leukemia With Resistance Or Intolerance To Prior Therapy In Europe. |
|
|
Jan 18, 2013 |
1389 |
| Scientists in North saving young lives; Cancer drug dosages raised after research. |
|
|
Jan 17, 2013 |
728 |
| Germany : Neoadjuvant Nanomedicines for vascular Normalization. |
|
|
Jan 17, 2013 |
316 |
| Research and Markets: IMA901 (Renal Cell Carcinoma) - Analysis and Forecasts to 2022 for US, EU5 and Japan. |
|
|
Jan 16, 2013 |
269 |
| Antineoplastic agents. |
|
|
Jan 16, 2013 |
103 |
| Chinese medicine formula "Weikang Keli" induces autophagic cell death on human gastric cancer cell line SGC-7901. |
Huo, Jiege; Qin, Fengxia; Caic, Xueting; Ju, Jianming; Hu, Chunping; Wang, Zhigang; Lu, Wuguang; Wan |
Report |
Jan 15, 2013 |
4051 |
| Antineoplastic and immunomodulating agents. |
|
|
Jan 12, 2013 |
297 |
| Devastated my cousin's leukaemia has returned; DearColeen THE STRAIGHT-TALKING PROBLEM PAGE. |
|
|
Jan 11, 2013 |
294 |
| Research and Markets: Carcinomas - Pipeline Review, H2 2012. |
|
|
Jan 11, 2013 |
355 |
| Chugai Grants Debiopharm Group Exclusive Worldwide License for Anti-cancer Agent. |
|
|
Jan 10, 2013 |
109 |
| Research and Markets: Closed Drug Transfer Systems. Therapeutic Markets, Strategies and Outlook. |
|
|
Jan 10, 2013 |
514 |
| Research and Markets: Leukemias - Pipeline Review, H2 2012. |
|
|
Jan 10, 2013 |
405 |
| ResearchMoz: Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail - Market Research Report. |
|
Report |
Jan 9, 2013 |
1428 |
| ResearchMoz: Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail - Market Research Report. |
|
Report |
Jan 9, 2013 |
1432 |
| 'Small-molecule Cancer Drug Revenues Will Reach $32.7 Billion in 2016' Predicts New Visiongain Report. |
|
|
Jan 8, 2013 |
1380 |
| Eisai Signs Agreement with Epizyme and Roche Molecular Systems to Develop Companion Diagnostic. |
|
|
Jan 8, 2013 |
946 |
| Noblepharma and Eisai Announce Japan Lunch of Antineoplastic Agent Gliadel(R) 7.7 mg Implant. |
|
Clinical report |
Jan 8, 2013 |
1162 |
| Chugai and Debiopharm Group Announce an Exclusive License Agreement for Anti-Cancer Agent, FF284 (Debio 1347). |
|
|
Jan 8, 2013 |
728 |
| Stemline Therapeutics' Lead Clinical Candidate, SL-401, Induces Another Complete Response in a Patient with a Drug-Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm. |
|
|
Jan 7, 2013 |
855 |
| Labcyte and FIMM Announce a Collaboration Enabling "Real-Time" Science to Advance Personalized Medicine in Cancer Treatments. |
|
|
Jan 7, 2013 |
754 |
| Research and Markets: Rencarex (Renal Cell Carcinoma)- Analysis and Forecasts to 2022. |
|
|
Jan 7, 2013 |
320 |
| University of Illinois Licenses Novel Anti-Cancer Therapies to StemPar Sciences. |
|
|
Jan 7, 2013 |
508 |
| Canada : Phase 3 DECISION Trial of Nexavar (sorafenib) Meets Primary Endpoint of Improving Progression-Free Survival in Patients with Radioactive Iodine Refractory Differentiated Thyroid Cancer. |
|
Clinical report |
Jan 4, 2013 |
212 |
| Germany : Phase III DECISION Trial of Nexavar(sorafenib) Meets Primary Endpoint of Improving Progression-Free Survival in Patients with Radioactive Iodine Refractory Differentiated Thyroid Cancer. |
|
|
Jan 4, 2013 |
398 |
| PharmaEngine and Guangzhou BeBetter Medicine Technology Signed a Collaboration and Research Agreement. |
|
|
Jan 3, 2013 |
367 |
| Phase 3 DECISION Trial of Nexavar (sorafenib) Meets Primary Endpoint of Improving Progression-Free Survival in Patients with Radioactive Iodine Refractory Differentiated Thyroid Cancer. |
|
Clinical report |
Jan 3, 2013 |
1886 |
| Tau Therapeutics Completes Phase 1 Clinical Trial of Mibefradil for Use in Oncology. |
|
|
Jan 3, 2013 |
515 |
| Research and Markets: Triple Analysis: Lung Cancer, Lymphoma and Antibodies. |
|
|
Jan 3, 2013 |
536 |
| Clinical results show that the experimental agent ibrutinib is highly active in CLL patients. |
|
Brief article |
Jan 1, 2013 |
230 |
| A common cancer therapy to avoid--and a new, effective solution. |
|
|
Jan 1, 2013 |
1190 |
| Watson Confirms Velcade Patent Challenge. |
|
|
Dec 28, 2012 |
856 |
| Spectrum Pharmaceuticals Announces Achievement of Primary Endpoint in Belinostat Registrational Trial. |
|
|
Dec 21, 2012 |
1202 |
| Research and Markets: Global Cervical Cancer Drug Pipeline Capsule - 2012 Update. |
|
|
Dec 21, 2012 |
439 |
| Research and Markets: Global Brain Cancer Drug Pipeline Capsule - 2012 Update. |
|
|
Dec 21, 2012 |
437 |
| What's this procedure? health focus. |
|
|
Dec 20, 2012 |
117 |
| What's this procedure? |
|
|
Dec 20, 2012 |
117 |
| Canada : Lorus Therapeutics and Brock University sign collaboration agreement to develop novel anticancer drugs. |
|
|
Dec 19, 2012 |
370 |
| Iran to Produce Antibody Medications for Treating Breast Cancer. |
|
|
Dec 19, 2012 |
313 |
| Workshop on Safe methods in Preparing and Dealing with Cancer Drugs. |
|
|
Dec 18, 2012 |
120 |
| e-Therapeutics provides update on progress of ETS2101 cancer trials. |
|
|
Dec 18, 2012 |
682 |
| Cellectis: An Innovative Anti-cancer Approach. |
|
|
Dec 18, 2012 |
950 |
| Eisai Inc. Divests U.S. Rights for GLIADEL Wafer (polifeprosan 20 with carmustine implant) to Arbor Pharmaceuticals. |
|
|
Dec 17, 2012 |
1760 |
| In the U.S., Approximately 80 Percent of Current Prescribers of Remicade and/or Rituxan Indicate They Would Prescribe Biosimilar Versions of These Agents Within a Year of Their Approval for Rheumatoid Arthritis. |
|
|
Dec 17, 2012 |
655 |
| Endocyte Selects Medidata Clinical Cloud to Support Oncology Studies. |
|
|
Dec 14, 2012 |
642 |
| Targeted Cancer Drugs The Launch Landscape to 2018. |
|
|
Dec 12, 2012 |
1079 |
| Alliance for Cancer Gene Therapy Funds Promising Leukemia Study - Patients in Remission More Than Two Years after Gene Therapy Treatment at UPenn. |
|
Report |
Dec 11, 2012 |
966 |
| Popular weight-loss drug orlistat may cause severe liver and kidney failure. |
|
|
Dec 11, 2012 |
433 |
| Isis Pharmaceuticals And AstraZeneca Form Strategic Alliance On RNA Therapeutics For Cancer. |
|
|
Dec 11, 2012 |
1470 |
| Aeterna Zentaris: Final Phase 2 Data Demonstrate Perifosine and Sorafenib Combination Therapy Well Tolerated by Heavily Pretreated Lymphoma Patients. |
|
|
Dec 11, 2012 |
1268 |
| Switzerland : Novartis long-term Phase III data show Ph+ CML patients on Tasigna achieved significantly deeper molecular response versus Glivec. |
|
|
Dec 11, 2012 |
288 |
| WIN Consortium and Pfizer Collaborate to Advance Personalized Cancer Care. |
|
|
Dec 10, 2012 |
564 |
| Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Chemotherapy-Induced Peripheral Neuropathy. |
|
|
Dec 10, 2012 |
863 |
| Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Chemotherapy-Induced Peripheral Neuropathy. |
|
|
Dec 10, 2012 |
868 |
| Switzerland : Roche reports positive studies of MabThera given by subcutaneous injection. |
|
Clinical report |
Dec 10, 2012 |
395 |
| Presentations Highlight Data on VELCADE[R] (bortezomib) as Retreatment or Maintenance in Patients with Multiple Myeloma. |
|
|
Dec 9, 2012 |
1547 |
| Calls for cancer drugs fund in Wales. |
|
|
Dec 8, 2012 |
196 |
| Halozyme Announced Roche Filed A Marketing Authorization Application For Subcutaneous MabThera. |
|
|
Dec 8, 2012 |
761 |
| TetraLogic Pharmaceuticals' Smac Mimetic Birinapant Selected for Oral Presentation at the 17th Japanese Foundation for Cancer Research - International Symposium on Cancer Chemotherapy. |
|
|
Dec 6, 2012 |
379 |
| Bio-Path Holdings to Expand Development of Liposomal Grb-2 into two Additional Indications: Triple Negative and Inflammatory Breast Cancers. |
|
|
Dec 6, 2012 |
1479 |
| Emily Bracamontes: Is The Sick Girl Possibly In Mexico? |
|
|
Dec 6, 2012 |
414 |
| Final Overall Survival Analysis of CONFIRM Shows a 4.1 Month Difference in Median Overall Survival When Using FASLODEX[R] (fulvestrant) Injection 500 mg Compared with 250 mg.1,2. |
|
|
Dec 5, 2012 |
1676 |
| AstraZeneca Updates US Label For FASLODEX[R] (fulvestrant) Injection. |
|
|
Dec 5, 2012 |
1209 |
| The Leukemia & Lymphoma Society Seeks to Fund Research in Six Critical Areas of Unmet Medical Need. |
|
|
Dec 4, 2012 |
462 |
| Pill launch ushers in 'new era of cancer treatment'. |
|
Clinical report |
Dec 3, 2012 |
303 |
| TOT Biopharm Opens High-Tech Production Facility in Suzhou. |
|
|
Dec 3, 2012 |
528 |
| Japanese researchers develop leukemia-prone iPS cells. |
|
|
Dec 3, 2012 |
186 |
| TOT Biopharm Opens High-Tech Production Facility in Suzhou. |
|
|
Dec 3, 2012 |
535 |
| Cancer drug 'may help eradicate latent HIV infection'. |
|
|
Dec 1, 2012 |
319 |
| Ginsenoside: novel agent for breast cancer? |
|
|
Dec 1, 2012 |
549 |
| Facilitating collaborations to develop combination investigational cancer therapies; workshop summary. |
|
Book review |
Dec 1, 2012 |
150 |
| New applications of flow cytometry in the clinical lab: the technology has gone from inside the cell to outside--and back. |
Shankey, T. Vincent |
Report |
Dec 1, 2012 |
2015 |
| New study supports 15-day fill program for oral cancer medications and again demonstrates lower adherence associated with higher patient out-of-pocket costs. |
|
|
Nov 30, 2012 |
861 |
| CEL-SCI Receives Key Japanese Patent for Its Investigational Phase III Cancer Therapy Multikine. |
|
|
Nov 28, 2012 |
978 |
| Agendia announces discovery of a gene signature that predicts response to a broad range of cancer drugs. |
|
|
Nov 27, 2012 |
536 |
| Ill Max, 2, is a Little Star for bravery; AWARD. |
|
|
Nov 26, 2012 |
163 |
| POSTCODE LOTTERY FOR PATIENTS; THE CONTROVERSY. |
|
|
Nov 26, 2012 |
102 |
| Cancer drugs trial joy for seriously ill Charlie. |
|
|
Nov 23, 2012 |
193 |
| Research and Markets: Disease and Therapy Review: Melanoma. |
|
|
Nov 22, 2012 |
442 |
| Research and Markets: Global Non-hodgkin's Lymphoma Drug Pipeline Capsule - 2012 Update. |
|
|
Nov 21, 2012 |
483 |
| Research and Markets: Global Non-small Cell Lung Cancer Drug Pipeline Capsule - 2012 Update. |
|
|
Nov 21, 2012 |
492 |
| Research and Markets: Global Oesophageal Cancer Drug Pipeline Capsule - 2012 Update. |
|
|
Nov 20, 2012 |
436 |
| Astellas Submits Supplemental New Drug Application to FDA for Tarceva as a First-Line Therapy in Genetically Distinct Form of Non-Small Cell Lung Cancer. |
|
|
Nov 20, 2012 |
1026 |
| Research and Markets: Global Acute Myeloid Leukaemia Drug Pipeline Capsule - 2012 Update. |
|
|
Nov 19, 2012 |
464 |
| Research and Markets: Global Bladder Cancer Drug Pipeline Capsule - 2012 Update. |
|
|
Nov 19, 2012 |
438 |
| Aeterna Zentaris: Data Demonstrate that Perifosine Combined with Temsirolimus Was Well Tolerated in Phase 1 Trial in Malignant Glioma. |
|
|
Nov 19, 2012 |
964 |
| United States Oncology Drug Delivery Preferences and Opportunities in Cancer Drug Delivery. |
|
|
Nov 19, 2012 |
878 |
| Research and Markets: Global Acute Myeloid Leukemia Epidemiology and Patient Flow Analysis - 2012. |
|
|
Nov 16, 2012 |
290 |
| Sensus Healthcare Announces Health Canada Approval. |
|
|
Nov 16, 2012 |
377 |
| Scottsdale Healthcare, TGen physicians lead worldwide study of new drug regimen for patients with pancreatic cancer. |
|
|
Nov 16, 2012 |
796 |
| OEP and NanoCarrier set up jv drug factory in Taiwan. |
Liang, Quincy |
Brief article |
Nov 16, 2012 |
299 |
| ALK inhibitors target non-small cell lung Ca. |
Wendling, Patrice |
|
Nov 15, 2012 |
1067 |
| Survey of Oncologists Reveals 98.9% of Physicians Experienced Cancer Drug Shortages in Last 12 Months. |
|
|
Nov 15, 2012 |
569 |
| Cancer drug introduces best treatment for multiple sclerosis. |
|
|
Nov 14, 2012 |
252 |
| Research and Markets: Global Malignant Melanoma Epidemiology and Patient Flow Analysis - 2012. |
|
|
Nov 14, 2012 |
274 |
| Bio-Path Holdings Successfully Completes Fourth Cohort in Phase I Clinical Trial of Lead Product Candidate Liposomal Grb-2 in Leukemia. |
|
|
Nov 14, 2012 |
1999 |
| National Patient Advocate Foundation Urges Ohio Legislature to Support Oral Chemotherapy Legislation. |
|
|
Nov 14, 2012 |
487 |
| Research and Markets: Global Chronic Myeloid Leukemia Drug Pipeline Capsule - 2012 Update. |
|
|
Nov 13, 2012 |
465 |
| Tiltan Pharma Announces Enrollment of First U.S. Patient in a Phase 2 Clinical Trial of TL-118, Anti-Angiogenic Treatment for Metastatic Pancreatic Cancer. |
|
|
Nov 13, 2012 |
1016 |
| World's first liver cancer 'chemo-bath' takes place in UK. |
|
|
Nov 13, 2012 |
425 |
| Blueprint Medicines Welcomes Daniel S. Lynch to its Board of Directors as Executive Chairman; Announces Permanent Appointment of Chris Varma, Ph.D., as Chief Executive Officer. |
|
|
Nov 13, 2012 |
868 |
| Collegiate Inventors Honored for Innovative Science and Technology Advances. |
|
|
Nov 13, 2012 |
1414 |
| Nanobiotix completes review of NBTXR3 treatment of six patients. |
|
|
Nov 13, 2012 |
138 |
| Clavis Pharma unveils disappointing data from metastatic pancreatic cancer study of CP-4126. |
|
|
Nov 12, 2012 |
182 |
| CellAct Pharma's Topoisomerase Inhibitor Demonstrates Success in Phase I Study Involving Adults with Heavily Pretreated Solid Tumors. |
|
|
Nov 12, 2012 |
584 |
| Foundation Medicine and AstraZeneca Announce Genomic Profiling Collaboration. |
|
|
Nov 12, 2012 |
484 |
| Research and Markets: Global Gastric Cancer Drug Pipeline Capsule - 2012 Update. |
|
|
Nov 12, 2012 |
437 |
| Research and Markets: Triple Analysis: Melanoma, Prostate Cancer and Peptides. |
|
|
Nov 12, 2012 |
573 |
